• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷霉素联合利福平、培氟沙星和亚胺培南对葡萄球菌的体外活性:采用时间杀菌曲线法的研究

In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.

作者信息

Quentin C, Saivin S, Lafferriere C, Noury P, Bebear C

出版信息

Drugs Exp Clin Res. 1987;13(4):219-24.

PMID:3476291
Abstract

The in vitro activity of fosfomycin alone and in combination with rifampin, pefloxacin and imipenem was studied by the time-kill method against staphylococci. Fosfomycin, pefloxacin and imipenem used at concentrations within the therapeutic range, exerted a bactericidal effect, whereas rifampin acted as a bacteriostatic drug. The combination of fosfomycin and rifampin was found to be antagonistic against rifampin-susceptible strains and indifferent for rifampin-resistant isolates. Fosfomycin combined with pefloxacin usually produced an indifferent effect. The interaction between fosfomycin and imipenem was mainly indifferent but synergism occurred with methicillin-resistant strains and antagonism was observed for one methicillin-susceptible isolate of Staphylococcus aureus.

摘要

采用时间杀菌法研究了磷霉素单独使用以及与利福平、培氟沙星和亚胺培南联合使用时对葡萄球菌的体外活性。在治疗范围内浓度使用的磷霉素、培氟沙星和亚胺培南具有杀菌作用,而利福平则起抑菌作用。发现磷霉素与利福平联合使用对利福平敏感菌株具有拮抗作用,而对利福平耐药菌株无影响。磷霉素与培氟沙星联合使用通常产生无影响的效果。磷霉素与亚胺培南之间的相互作用主要是无影响,但对耐甲氧西林菌株有协同作用,并且在一株甲氧西林敏感金黄色葡萄球菌分离株中观察到拮抗作用。

相似文献

1
In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.磷霉素联合利福平、培氟沙星和亚胺培南对葡萄球菌的体外活性:采用时间杀菌曲线法的研究
Drugs Exp Clin Res. 1987;13(4):219-24.
2
[In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].磷霉素与利福平、培氟沙星及亚胺培南联合对葡萄球菌的体外作用(液体培养基棋盘法)
Pathol Biol (Paris). 1987 Feb;35(2):153-7.
3
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.耐甲氧西林金黄色葡萄球菌对亚胺培南及其他抗菌药物的体外敏感性
Chemioterapia. 1987 Aug;6(4):261-3.
4
[In vitro study of the effects of an imipenem-fosfomycin combination against clinical strains of Staphylococcus].亚胺培南-磷霉素联合用药对金黄色葡萄球菌临床菌株作用的体外研究
Pathol Biol (Paris). 1986 Dec;34(10):1055-9.
5
[In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].头孢孟多-磷霉素联合用药对耐甲氧西林葡萄球菌的体外研究
Pathol Biol (Paris). 1984 Jun;32(5 Pt 2):528-31.
6
[Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination].[协同作用、相加作用、无关作用、拮抗作用和优势作用。优势作用与抗生素联合应用]
Pathol Biol (Paris). 1987 May;35(5):495-500.
7
In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin.亚胺培南对肠球菌和葡萄球菌的体外活性以及与替考拉宁、磷霉素和利福平有高协同率的证据。
Antimicrob Agents Chemother. 1986 Nov;30(5):813-5. doi: 10.1128/AAC.30.5.813.
8
In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.利奈唑胺联合多西环素、磷霉素、左氧氟沙星、利福平及万古霉素对甲氧西林敏感金黄色葡萄球菌的体外活性
Rev Esp Quimioter. 2006 Sep;19(3):252-7.
9
[Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].环丙沙星、氧氟沙星和培氟沙星单独及联合应用对D组链球菌菌株的杀菌动力学比较
Pathol Biol (Paris). 1988 May;36(5):403-9.
10
Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.磷霉素与β-内酰胺类抗生素对葡萄球菌和需氧革兰氏阴性杆菌的协同作用。
Drugs Exp Clin Res. 1986;12(12):943-7.

引用本文的文献

1
Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies.磷霉素作为全身感染管理的联合用药。对其体外和体内研究协同特性的系统评价。
Antibiotics (Basel). 2020 Aug 10;9(8):500. doi: 10.3390/antibiotics9080500.
2
Fosfomycin-daptomycin and other fosfomycin combinations as alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.磷霉素-达托霉素和其他磷霉素联合治疗耐甲氧西林金黄色葡萄球菌实验性异物感染的替代疗法。
Antimicrob Agents Chemother. 2013 Jan;57(1):606-10. doi: 10.1128/AAC.01570-12. Epub 2012 Oct 22.
3
Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.
磷霉素及其与利奈唑胺、万古霉素和亚胺培南联合应用对耐万古霉素金黄色葡萄球菌引起的实验性腹膜炎模型的疗效。
Eur J Clin Microbiol Infect Dis. 2011 Jan;30(1):89-95. doi: 10.1007/s10096-010-1058-0. Epub 2010 Sep 16.
4
Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.培氟沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 May;37(5):628-68. doi: 10.2165/00003495-198937050-00003.